|
(2R,5S,13AR)-8-甲氧基-7,9-二氧代-2,3,4,5,7,9,13,13A-八氢-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 氧氮杂环庚烷-10-羧酸
|
|
|
- CAS号:
- 1616342-45-0
- 英文名:
- (2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid
- 英文别名:
- BNKY010-BC01;Bictegravir Impurity 12;Chlorfenvinphos Impurity 4 ((E)-Chlorfenvinphos);(2R,5S,13aR)-8-Methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2;(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2;(2R,5S)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid;(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid;(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid;(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid;(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid
- 中文名:
- (2R,5S,13AR)-8-甲氧基-7,9-二氧代-2,3,4,5,7,9,13,13A-八氢-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 氧氮杂环庚烷-10-羧酸
- 中文别名:
- 比克替拉韦杂质12;(2R,5S,13AR)-8-甲氧基-7,9-二氧代-2,3,4,5,7,9,13,13A-十氢-2,5-甲酮吡啶并[1',2':4,5]吡嗪[2,1-B][1,3]氧氮杂-10-羧酸;(2R,5S)-8-甲氧基-7,9-二氧代-2,3,4,5,7,9,13,13A-八氢-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 氧氮杂环庚烷-10-羧酸;(2R,5S,13AR)-2,3,4,5,7,9,13,13A-八氢-8-甲氧基-7,9-二氧代-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]氧氮杂卓-10-羧酸;(2R,5S,13AR)-2,3,4,5,7,9,13,13A-八氢-8-甲氧基-7,9-二氧代-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]氧氮杂卓-10-羧酸;(2R,5S,13AR)-8-甲氧基-7,9-二氧代-2,3,4,5,7,9,13,13A-八氢-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 氧氮杂环庚烷-10-羧酸;(2R,5S,13AR)-8-甲氧基-7,9-二氧代-2,3,4,5,7,9,13,13A-八氢-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 氧氮杂环庚烷-10-羧酸
- CBNumber:
- CB63145861
- 分子式:
- C15H16N2O6
- 分子量:
- 320.3
- MOL File:
- 1616342-45-0.mol
|